Dova Pharmaceuticals

Dova Pharmaceuticals is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. The United States Food and Drug Administration has approved DOPTELET (avatrombopag), which is an orally administered thrombopoietin receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure. The company is also conducting a trial in chemotherapy-induced thrombocytopenia.
  • TickerDOVA
  • ISINUS25985T1025
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

Laura Chico

Down But Not Out: Looking Ahead to 3Q19 Biotech Reporting

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Laura Chico

Down But Not Out: Looking Ahead to 3Q19 Biotech Reporting

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

5 directors sold after exercising options/sold

Five Directors at Dova Pharmaceuticals Inc sold after exercising options/sold 13,111 shares at between 27.900USD and 28.000USD. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading a...

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ValuEngine Rating and Forecast Report for DOVA

ResearchPool Subscriptions

Get the most out of your insights

Get in touch